SlideShare a Scribd company logo
1 of 43
Download to read offline
340B Recertification & Audit
Changes/Tips
Ryan DiGiovanni, PharmD, 340B ACE
ryan_digiovanni@rush.edu
Disclosures
• No conflict of interest
• Information provided should not be construed as legal advice.
Bio
Ryan DiGiovanni – PharmD, 340B ACE
Founder - EPL Health
• Build and support 340B compliance & operations for
covered entities (CE)
• Entities we serve: FQHC, FQHC-LA, DSH, CAH, RW
Clinics
340B Manager- Rush University Health System
• 2 Disproportionate Share Hospital (DSH)
• 1 Hemophilia Treatment Center (HTC)
• 700+ Contract Pharmacy
• 3 Third Party Administrators
340B Satellite Office
340B
Coordinator
Expansion &
Growth
All Vendor
Management
Compliance &
Audit
Consolidated
Reporting
Agenda
+ Hot Topics
+ Audit Trends & Readiness
+ 340B Data Request Review
Poll
1. What entity type are you?
a. Hospital
b. Grantee
2. What do we want to spend most of our time on?
a. 340B Hot Topics & HRSA Audit Impact
b. Annual Recertification
c. HRSA Audit Data Request List
Hot Topics: Timeline of Events
2019
Guidances Not Legally Binding
Trump Administration issued an executive
order (Federal Register, 84 Fed. Reg.
55235-55238 Oct 15, 2019) that rendered
guidance documents published by federal
agencies as non-binding and not legally
enforceable.
Manufacturer Restrictions Begin
Effective July 1, 2020, Eli Lilly
announces it will no longer sell
Cialis at 340B ceiling prices to
covered entities through contract
pharmacy arrangements
2020
2020
HRSA Loosens Audit Findings
The Government Accountability Office (GAO)
issues report, stating HRSA began to relax its
auditing standards, only issuing findings
non-compliance that are directly related to
340B Program Statute.
2022
Genesis v. Azar Appeal
Genesis appeal argued HRSA audit findings were
based on interpretation of ‘patient’ defined in guidance,
contradicting the plain language of the law and
overextended HRSA’s enforcement capability
HRSA ultimately reinstated Genesis in the 340B
Program, voided its audit, and the district court
dismissed the lawsuit.
2023
1st Ruling in favor of Manufacturers
U.S. Court of Appeals for the 3rd Circuit rule in favor
of Sanofi-Aventis U.S. v. HHS et al. Not required to
provide 340B price at contract pharmacy. Cases
raising similar legal questions are pending in the
District of Columbia and 7th Circuits.
Hot Topics: Genesis V Agar & Guidance on Patient Definition
Diversion
Hot Topics: Op-Ed
❖ Background/Discussion
Currently, HRSA’s authority is limited only to program statutes and regulations*
- Mega-guidance and other common guidelines (i.e. Patient Definition) are not enforceable findings
during a HRSA audit*
❖ Tips/Warnings
- May drive greater attention to enforceable laws/regulations. Recommend special attention to
specific aspects of program:
- Accuracy/Eligibility information in OPAIS database
- Recertification/Registration
- Policy & Procedure
- annual review and update
- Duplicate Discount Prevention
- Medicaid Exclusion File, State Policy
- Maintained auditable records
- Compliance with HRSA Audit
-
*based on presentation date 02/21/2023. Statements outlined are opinion based and/or subject to change
Recertification
Recertification - General
❖ Background/Discussion
- Annual recertification is mandatory for 340B covered entities
- Authorizing Official & Primary Contact get email notifications
❖ Requirements
- Must ensure all information is accurate and up to date
- Must update and attest before recertification window ends
- ONLY AO can Attest (PC can update/make changes)
Entity Type Recertification Window
FQHCs & Most Grantee January 30, 2023 - February 27, 2023
Hospitals Summer 2023
Title X family planning clinics, STD,
TB clinics
No dates yet
Recertification - General
❖ Tips/Warnings
- Have MCR/Grant documents ready for upload
- Verify addresses match on eligibility forms to OPAIS
- Ensure each registered site is still operational/eligible
- Grantees: falls under scope of grant
- Hospitals: outpatient charges/expenses on MCR lines 50-118*
- Have you Medicaid billing numbers and/or NPI numbers ready
- Ensure contact information for AO and PC is correct
❖ Tools/References
- Get help:
- ApexusAnswers@340bpvp.com
- 888-340-2787
- Online Resources:
- Recertifying a CE
*FAQ ID: 4301. HRSA 340B FAQ Search (340bpvp.com)
Start Session
Go to links provided in Autorizing Official (AO) or Primary
Contact (PC) email. Sign in to HRSA 340B OPAIS database
(Office of Pharmacy Affairs 340B OPAIS (hrsa.gov)) to start.
Recertification tasks will appear in My Dashboard section
under ‘My Task’ tab’. Click on ‘Recertification’
Summary Page
The recertification summary page will outline items for
you that must be updated, and items that should be
reviewed. “Update” = required, “Review” =
Recommended. Read these then hit ‘Continue
AO Signs & Attests
After all information is updated and reviewed, the Authorizing
Official must check the attestation box, and ‘Submit’
Go Through Each Tab
- Go through each tab Qualification Info,
Attachments Info, Medicaid Billing,
Parent/Child.
- Read any ‘update’ or ‘review’ messages.
- Click the Edit link to review the details pages
and make necessary updates.
Recertification - Uploading Attachments
❖ Background/Discussion
- This is usually the biggest issue requiring additional follow up from HRSA
❖ Tips/Warnings
- Only Microsoft Excel (xlsx) and Adobe PDF formats are allowed.
- File size is limited to 50MB.
- Files must not be password protected.
- Number of uploaded files must not exceed 10 files per submission
❖ Tools/References
- ApexusAnswers@340bpvp.com
- 888-340-2787
- Uploading Documents
Recertification - Cost Report
- If you change the entity's Qualification Information during recertification or if the most recent cost report is out of date, the system will prompt
you to upload updated supporting documentation from the latest Medicare cost report.
- If you change the entity’s Filing Date, and if the Filing Date is more than 5 months and 5 days after the Cost Reporting Period end date then the
system will display a warning message and require you to upload the signed/dated Worksheet S from your latest filed Medicare Cost Report.
Changing AO - Recertification
The current AO or PC may submit an AO change request. Only an AO change can be requested in a Change Request when the entity is undergoing
recertification.
On the Covered Entity Details page, type the email address for the new AO and click the Search button.
Medicaid - Recertification
This information is used to populate the medicaid exclusion file
‘At this site, will the covered entity bill Medicaid fee-for-service for drugs purchased at
340B prices? Yes = Carve-in, No = Carve out
Duplicates cannot be created because upon the save in the Edit Medicaid and NPI
Info by State pop-up window, the duplicates will be ignored. However, if duplicates
already exist, it is up to the AO and PC to correct them either by associating each
duplicated number with a different State or removing the duplicates from the current
State.
Audit Overview &
Expectations
HRSA Audit Agenda
What to Expect:
Introductions – Consider one person to coordinate if remote
Scripted Reason for Audit
Agenda timing will vary
Auditor will review housekeeping items that may still need to be uploaded
Begin with a general overview of program and auditor questions
Sampling, Transaction Testing, Provider Review, Claim Review
Follow Up On Any Outstanding Items
Closing
HRSA Selection Criteria
Maximum number of random samples
selected is 56
28 samples from largest universe
If any universe is 300 or less there will never be
more than 10%
5 samples are judgmental which will always
come from the largest dataset
❖ Background/Discussion
Since 2020, HRSA has implemented consistent data sampling practices:
Provider Administered Drugs Sample
• Time of Dispense or Administration
• Patient Status
• Drug Order and Dose
• Provider Name - If Health Care Professional Stance utilized, show documentation to
substantiate care
• Location – If not from an eligible location, demonstrate the continuum of care via
primary care visit or referral documentation.
• Payer
Retail Claims Drug Sample
• Date of Visit to Substantiate Care
• Location Where Prescription Was Written
• Prescription Order
• Medication Present in Med list
• Medication Present in Provider Documentation
• Referral Origination and Care Note Back (if applicable, best practice)
• Payer – If in-House Retail and FFS Medicaid will want to see clarification codes
Billing Claim Form Review
❖ Background/Discussion
If carving-in Medicaid, expect auditor to review billing
- Will need to verify NPI-UB04 Box 56 & CMS 1500 Box 33
- Confirmation of any state modifiers
❖ Requirements
- Only required to upload Medicaid FFS claim
340B Audit Data
Request List
340B Audit Data Request List
❖ Background/Discussion
Reviewed and updated beginning of every fiscal year
❖ Requirements/New Information
1. Policy & Procedures
2. Eligibility
3. 340B Universe for Sample Period
4. Provider List
5. Purchasing
6. Contract Pharmacy
7. Entity-Owned Pharmacy
8. Self-Disclosures
9. Medicaid Billing
10. Re-audit
❖ Tips/Warnings
❖ Tools/References
- 340B Data Request List Sample pdf
1. Policies & Procedures
❖ Background/Discussion
- All CE’s: loosened eligibility of providers, locations and acceptable patient records during public health
emergency
- Hospitals: Definition of eligible site when location is not on the MCR yet or for special circumstance
❖ Requirement
- Policy & Procedures must reflect the covered entities eligible location definition, provider and record-keeping
requirements to allow for this
❖ Tips/Warnings
- Ensure P&P’s updated to provide entity this wiggle room
- Auditor may ask about emergency activations of locations within sampling period
❖ Tools/References
- HRSA FAQ ID: 4301
- Public Health Emergency Considerations
2.B. Eligibility - Hospitals
❖ Background/Discussion
- More transparency of site eligibility when reviewing sample data
❖ Requirement
New in FY23: Section 2B - Include all applicable Medicare Cost Reports
- Most recently filed MCR for the start of the audit period;
- MCR used at the time of the last recertification; and
- MCR filed since the start of the sample period through the date of audit
- The encrypted signature on Worksheet S must be provided with all MCRs
-
2.G. Eligibility - Hospitals
❖ New Requirements
2.C - Item G Added FY21
- The 340B ID
- Name of each offsite outpatient facility as identified on OPAIS
- Address of the off-site outpatient facility
- Worksheets A & C: Line Number and Cost Center Description
- Trial balance name and department code/account
- The location code or shorthand used to identify the site in the electronic health record
(EHR)
- Indicate if 340B drugs are utilized during encounters at the site
-
2.E. Eligibility - Hospitals
❖ Background/Discussion
HRSA wants hospital eligibility documents to be easier to decipher
❖ New Requirements
2.E. Hospitals Requiring Contract with State or Local Government
- New FY22: must highlight the following in the contract:
■ Provision whereby indigent care provided by Hospital
■ Name of Hospital and Government Agency
■ Signatures of Hospital and Government Agency
■ Effective Dates of the Contract
Private non-profit and hospitals granted government powers must prove non-profit status
documentation.
- IRS Form 990, Hospital Charter, Articles of incorporation, Bylaws, 501(c)(3)
2. Eligibility - Grantees
❖ Background/Discussion
- Auditor will likely go through services provided at each associated clinic during an opening conference.
- Crosswalks create bridge to cipher eligible locations listed on OPAIS to EHR record locations to Billing/Shipping Locations
- Will make for seamless preparation and audit
❖ Requirements
- Notice of Grant Award and/or sub grantee documentation
- EHB Forms 5A and 5B. 5C is not on list but have available as well.
- EHB Crosswalk – Include a list of locations where health care services are provided for which the grantee deems itself responsible
❖ Tips/Warnings
Creating EHB Crosswalk:
1. Start with OPAIS extract
2. Crosswalk each associated site’s physical address, verify they match the EHB
3. Add bill to and ship to columns and populate with appropriate addresses
4. Add location code or shorthand to identify the site in the health record
5. Include additional columns to indicate if actively purchasing 340B drugs and add billing numbers if carving in Medicaid.
❖ Tools/References
- Apexus Sample Data Request
- 340B Crosswalk - Basic Template
3.A. Universe & Program Narrative
❖ Requirements
3.A: Not New - Include a narrative describing the methodology and
system or software used to gather the data: note any limitations,
exclusions, and inclusions (e.g., reversals, direct purchases, etc.)
Universe Methodology/System/
Software
Report Name(s) Notes
Mixed Use Mixed Use TPA Includes Reversals and direct
purchases, explain limitations,
or any exclusions
Child Site EHR or TPA
In-House Rx TPA
Contract Rx TPA
3.A. Universe & Program Narrative
❖ New Requirements
3A. - Define each area of service on the spreadsheet(s) with column
headings name and indicate which area the spreadsheet represents
❖ Tips/Warnings
Copy the column headers and add into the program narrative
Create a key for abbreviations and/or unknown terms
- For example:
- CSN = Contact Serial Number = Unique Patient ID
- MRN = Medical Record Number
- ESN = Encounter Serial Number
3.A. Universe & Program Narrative
❖ Tips/Warnings
- Review ALL data prior to upload
- Remove non-covered outpatient drugs
- exclude limiting definition drugs (vaccines), orphan drugs
- pvp-value added drugs (use pvp price file for this)
- Only report data elements that have been asked for
- REMOVE PHI (just Rx number, MRN, or tracking number)
- BUT Keep copies of original records on file for better cross-walking
during audit period
4. Provider List
❖ Requirements
- Name
- NPI
- Employment type (Employed, Resident, Contract)
- Start Date
- End Date
❖ Tips/Warnings
- Create ‘Type 2’ dimension- table to address any potential gaps in employment and/or change in employment type
- Be prepared to show the auditor proof of employment, contract, or credentialing for providers during the onsite/remote
audit
Provider Map ID First Name Last Name NPI Employment Type Start Date End Date isActive
1 John Doe 1234564789 Dedicated 1/1/2010 3/1/2015 N
2 John Doe 1234564789 Contracted 3/2/2015 Y
5. Purchasing Docs
❖ Requirements
- List all accounts – for all universes – including if applicable (340B, GPO, WAC, CSOS) by 340B ID
- Include wholesaler name
- Include a column for bill to and ship to which will assist in OPAIS address verification
- Provide Invoice example for each account – embed or list corresponding file name
- Provide all purchases (340B ONLY) - embed or list corresponding spreadsheet name
❖ Tips/Warnings
- Update on a rolling 6-month basis to be in HRSA audit ready state
- Create ‘Type 2’ dimension- table to address any potential gaps in employment and/or
change in employment type
5. Purchasing Crosswalk Example
Clinic /
Hospital /
Retail
Account
Location 340B ID
Ship To
Address
Bill To
Address
ACCOUN
T #
DESIGNATI
ON
WHOLESALE
R
Invoice Name
Reference
Purchasing
Record
Off-Site Clinic
CE
Physicians
Group
HRSA
ID
336 S.
Jefferson
113 W.
Hickory
XYZ 340B Add Name
5.B. HRSA ID
Invoice
7805XXX
5.C. HRSA ID
Wholesaler
Purchasing
Record
Off-Site Clinic
CE
Physicians
Group
HRSA
ID
336 S.
Jefferson
113 W.
Hickory
XYZ GPO Add Name
5.B. HRSA ID
Invoice
387XXXXX
NA
Hospital CE Hospital
HRSA
ID
113 W.
Hickory
Street
113 W.
Hickory
XYZ GPO Add Name
5.B. Mixed Use
GPO Invoice
995XXXXX
NA
Hospital CE Hospital
HRSA
ID
113 W.
Hickory
Street
113 W.
Hickory
XYZ 340B Add Name
5.B. HRSA ID
340B Invoice
3087XXXXXX
5.C. HRSA ID
Wholesaler
Purchasing
Record
6A. Contract Pharmacy Crosswalk
❖ New Requirements
- 6.A. must disclose whether pharmacy is being used by the covered entity
- 6.C. Provide last Independent Audit of Contract Pharmacies
- 6.D. Provide supporting documentation of internal contract pharmacy audits during start of sample period through date of audit.
❖ Tips/Warnings
- Create ‘Type 2’ dimension- table
1. Can use OPAIS Extract of all contact pharmacies to get you started and minimize to the following columns:
- 340B ID, Pharmacy Name, Address 1, Address 2, City, State, Zip, Contract Approval Date
2. Then add the following additional columns:
- TPA, Pay on: Dispense or Replenishment, True Up Terms, Utilized or Not Utilized, Wholesaler, Account Number, Invoice, Contract Name
CONTRACT PHARMACY CROSSWALK EXAMPLE
340
B ID
Retail
Account
Location Address
Contract
Approval
Date
TPA Pay on
True
Up
Active Wholesaler Account # Invoice Name Contract Name
HRS
A ID
Contract
Pharmacy
Uptown
Drug Store
N Bus
hwy
date from
extract
Macro
Replenis
hment
180 Utilized Cardinal XYZ or 123
CAHXXXXXX-00
copy of invoice
List contract file name
when first registered or
embed copy
HRS
A ID
Contract
Pharmacy
Drug Stores
on the
Boulevard
S BLVD
Ste A
date from
extract
Macro
Replenis
hment
180 Utilized Cardinal XYZ or 124
CAHXXXXXX-00
copy of invoice
List contract file name
when first registered
HRS
A ID
Contract
Pharmacy
Walgreens
#0XYZ
S BLVD
date from
extract
Walgree
ns
Dispens
e
60 Utilized Amerisource XYZ or 126
CAHXXXXXX-00
Walgreens copy of
invoice
List contract file name
when first registered
HRS
A ID
Contract
Pharmacy
PHY
S
Jefferso
n
date from
extract
ScriptPr
o
Dispens
e
60 Utilized Amerisource XYZ or 127
CAHXXXXXX-00
Walgreens copy of
invoice
List contract file name
when first registered
HRS
A ID
Contract
Pharmacy
Walmart
001
Grand
Ave
date from
extract
Macro
Replenis
hment
180 Utilized McKesson XYZ or 128
CAHXXXXXX-00
Walmart
Invoice_AXXXXX
List contract file name
when first registered
HRS
A ID
Contract
Pharmacy
Walmart
005
Range
RD
date from
extract
Macro
Replenis
hment
180
Not
Utilized
McKesson XYZ or 130 Not Utilized
List contract file name
when first registered if in
audit window, if not list
term date or NA
7. Entity-Owned Pharmacies
❖ New Requirements
Provide a list of pharmacies, other than contract pharmacies utilized during the start of the sample period through the audit start date.
- Pharmacy name and address
- Whether pharmacy is located within a registered off-site facility/grant-associated Site
Type of pharmacy (Retail/Community, Infusion, Specialty, Compounding, Mixed-Use)
- Documentation to demonstrate ownership
- Pharmacy license, Business license, Certificate of liability insurance, or Listing of pharmacy on the CEs grant or MCR and corresponding trial
balance
❖ Tips/Warnings
- Also adding in OPAIS Pharmacy ID, OPAIS Contract ID, Pharmacy NPI number would provide more efficient tracking
and reference ID columns.
- Can use these columns for Xlookup/Vlookup functions to audit pharmacy dispensing data across all
pharmacies/TPAs.
❖ Tools/References
340B Crosswalk - Basic Template
9. Medicaid Documents
❖ Requirements
- Provide Medicaid FFS billing document for each covered entity site (340B ID) that carves in
- Every NPI, every Medicaid number, for EVERY 340B ID
340B ID State State Requirements NPI(s)
State assigned
Medicaid number(s)
Medicaid FFS Claim Form
CAH12345-00 MN UD 123 XYZ [Embedded document]
CAH12345-01 MN UD 1234 XYZ [Embedded document]
CAH12345-02 MN UD 12345 XYZ [Embedded document]
Key Takeaway - 340B DRL
- 340B Program Narrative, with data methodology table, and column header
crosswalk
- Location Crosswalk
- Purchasing Crosswalk
- Contract Pharmacy Crosswalk
- Medicaid Crosswalk
Appendix
340B News: Genesis v Agar
Genesis Healthcare Inc. v Alex Azar:
Genesis, an FQHC, removed from 340B program after 340B audit findings of Diversion. (qualified rx’s as 340B eligible from ‘non-eligible
locations’)
Bullet Points:
• After being removed from 340B, Genesis filed suite that argued that the audit findings, which were based on adherence to HRSA’s
interpretation of ‘patient’ defined in guidance, contradict the plain language of the law and overextended HRSA’s enforcement capability
• HRSA ultimately reinstated Genesis in the 340B Program, voided its audit, and the district court dismissed the lawsuit.
• Genesis has since appealed the dismissal, pressing the court for a declaratory judgment that the 340B patient definition issued through
guidance is illegal. Oral arguments for the appellate case were heard in March 2022.
Historical perspective regarding the case:
• In 2019, the Trump Administration issued an executive order (Federal Register, 84 Fed. Reg. 55235-55238 Oct 15, 2019) that rendered
guidance documents published by federal agencies as non-binding and not legally enforceable.
• Mfg have taken advantage by restricting 340B drugs through contract pharmacy channels, as outlined in non-binding guidance
• The Government Accountability Office (GAO) issued a report in December 2020 on HRSA’s efforts to oversee CE compliance with 340B
Program requirements. The report noted that, starting in the fall of 2019, HRSA began to relax its auditing standards by which it would only
issue findings for areas of non-compliance that are directly related to requirements stipulated in the 340B Program statute.
• 340B Statute: https://www.hrsa.gov/sites/default/files/hrsa/rural-health/phs-act-section-340b.pdf
340B News: Genesis v Agar
Conclusion:
Broadening the patient definition may provide CEs with significant value in terms of 340B savings optimization, and may
be permissible according to law, given the lack of specificity of “patient definition” outlined in 340B Program statute and
regulations.
Considerations:
• Elements of case are directly applied to grantee, not a hospital
• Current HRSA audit standards reflect the agency’s limited enforcement authority, HOWEVER, these standards could
evolve should they receive rule-making authority and/or the ability to enforce 340B Program guidance.
Potential Next Steps:
• Assess for scenarios where a “continuum of care” relationship may apply
• Review non-reimbursable hospital departments (e.g., Line 190 clinics) that may be integral to the CE.
• Quantify the financial impact of broadening the Patient definition
• Ensure any modifications to patient definition are clearly articulated in policies and procedures.

More Related Content

What's hot

Drug promotional literature
Drug promotional literatureDrug promotional literature
Drug promotional literatureVani Jayaraman
 
Understanding pharmacovigilance
Understanding pharmacovigilanceUnderstanding pharmacovigilance
Understanding pharmacovigilancefinenessinstitute
 
100 Cases in Emergency Medicine and Critical Care, First Edition (Mistry, Dip...
100 Cases in Emergency Medicine and Critical Care, First Edition (Mistry, Dip...100 Cases in Emergency Medicine and Critical Care, First Edition (Mistry, Dip...
100 Cases in Emergency Medicine and Critical Care, First Edition (Mistry, Dip...KeboBataa
 
SOFTWARE USED IN P'epidemiology.pdf
SOFTWARE USED IN P'epidemiology.pdfSOFTWARE USED IN P'epidemiology.pdf
SOFTWARE USED IN P'epidemiology.pdfvarshawadnere
 
Presentation: Periodic safety update reports
Presentation: Periodic safety update reportsPresentation: Periodic safety update reports
Presentation: Periodic safety update reportsTGA Australia
 
Common Pediatric Infections
Common Pediatric InfectionsCommon Pediatric Infections
Common Pediatric InfectionsDang Thanh Tuan
 
6. 의료기기 임상시험 박종철
6. 의료기기 임상시험 박종철6. 의료기기 임상시험 박종철
6. 의료기기 임상시험 박종철Kwangmo Yang
 
Prescription event monitoring
Prescription event monitoringPrescription event monitoring
Prescription event monitoringReyaz Bhat
 
Safety reports. addendum to the clinical overview. aco
Safety reports. addendum to the clinical overview. acoSafety reports. addendum to the clinical overview. aco
Safety reports. addendum to the clinical overview. acoAzierta
 
Quality use medicine
Quality use medicineQuality use medicine
Quality use medicineFARAZULHODA
 
Pharmacovigilance Overview
Pharmacovigilance OverviewPharmacovigilance Overview
Pharmacovigilance OverviewSivasankaranV
 
A child with fever and seizure in Thai
A child with fever and seizure in ThaiA child with fever and seizure in Thai
A child with fever and seizure in ThaiThorsang Chayovan
 
Paediatrics treatment guidelines Govt of India
Paediatrics treatment guidelines Govt of IndiaPaediatrics treatment guidelines Govt of India
Paediatrics treatment guidelines Govt of IndiaDr Jitu Lal Meena
 
02. forecasting consumption method
02. forecasting   consumption method02. forecasting   consumption method
02. forecasting consumption methodMmedsc Hahm
 

What's hot (17)

Drug promotional literature
Drug promotional literatureDrug promotional literature
Drug promotional literature
 
01 introduction to aefi
01 introduction to aefi01 introduction to aefi
01 introduction to aefi
 
Understanding pharmacovigilance
Understanding pharmacovigilanceUnderstanding pharmacovigilance
Understanding pharmacovigilance
 
100 Cases in Emergency Medicine and Critical Care, First Edition (Mistry, Dip...
100 Cases in Emergency Medicine and Critical Care, First Edition (Mistry, Dip...100 Cases in Emergency Medicine and Critical Care, First Edition (Mistry, Dip...
100 Cases in Emergency Medicine and Critical Care, First Edition (Mistry, Dip...
 
Qc in clinical trials
Qc in clinical trialsQc in clinical trials
Qc in clinical trials
 
SOFTWARE USED IN P'epidemiology.pdf
SOFTWARE USED IN P'epidemiology.pdfSOFTWARE USED IN P'epidemiology.pdf
SOFTWARE USED IN P'epidemiology.pdf
 
Presentation: Periodic safety update reports
Presentation: Periodic safety update reportsPresentation: Periodic safety update reports
Presentation: Periodic safety update reports
 
Common Pediatric Infections
Common Pediatric InfectionsCommon Pediatric Infections
Common Pediatric Infections
 
6. 의료기기 임상시험 박종철
6. 의료기기 임상시험 박종철6. 의료기기 임상시험 박종철
6. 의료기기 임상시험 박종철
 
Prescription event monitoring
Prescription event monitoringPrescription event monitoring
Prescription event monitoring
 
Safety reports. addendum to the clinical overview. aco
Safety reports. addendum to the clinical overview. acoSafety reports. addendum to the clinical overview. aco
Safety reports. addendum to the clinical overview. aco
 
Quality use medicine
Quality use medicineQuality use medicine
Quality use medicine
 
Pharmacovigilance Overview
Pharmacovigilance OverviewPharmacovigilance Overview
Pharmacovigilance Overview
 
A child with fever and seizure in Thai
A child with fever and seizure in ThaiA child with fever and seizure in Thai
A child with fever and seizure in Thai
 
Paediatrics treatment guidelines Govt of India
Paediatrics treatment guidelines Govt of IndiaPaediatrics treatment guidelines Govt of India
Paediatrics treatment guidelines Govt of India
 
02. forecasting consumption method
02. forecasting   consumption method02. forecasting   consumption method
02. forecasting consumption method
 
Pneumonia in children
Pneumonia in childrenPneumonia in children
Pneumonia in children
 

Similar to 2023 Compliatric Webinar Series - 340B Recertification and Audit Changes

2023 Compliatric Webinar Series - 340B ESP Overview from a Participating CE
2023 Compliatric Webinar Series - 340B ESP Overview from a Participating CE2023 Compliatric Webinar Series - 340B ESP Overview from a Participating CE
2023 Compliatric Webinar Series - 340B ESP Overview from a Participating CECompliatric Where Compliance Happens
 
Translating compliance requirements into action items 340B
Translating compliance requirements into action items 340BTranslating compliance requirements into action items 340B
Translating compliance requirements into action items 340BCompliatric
 
340B Drug Pricing Under the Microscope
340B Drug Pricing Under the Microscope340B Drug Pricing Under the Microscope
340B Drug Pricing Under the MicroscopePolsinelli PC
 
Identifying & resolving 340b duplicate discounts Kalderos
Identifying & resolving 340b duplicate discounts Kalderos Identifying & resolving 340b duplicate discounts Kalderos
Identifying & resolving 340b duplicate discounts Kalderos stevenzielinski1
 
HRSA Audits What You Need to Prepare For 2016-06-01-final
HRSA Audits What You Need to Prepare For 2016-06-01-finalHRSA Audits What You Need to Prepare For 2016-06-01-final
HRSA Audits What You Need to Prepare For 2016-06-01-finalsteven zielinski
 
Navigating manufacturer designations for 340 b contract pharmacies compliatric
Navigating manufacturer designations for 340 b contract pharmacies compliatricNavigating manufacturer designations for 340 b contract pharmacies compliatric
Navigating manufacturer designations for 340 b contract pharmacies compliatricCompliatric Where Compliance Happens
 
Navigating manufacturer designations for 340 b contract pharmacies compliatric
Navigating manufacturer designations for 340 b contract pharmacies compliatricNavigating manufacturer designations for 340 b contract pharmacies compliatric
Navigating manufacturer designations for 340 b contract pharmacies compliatricCompliatric
 
Medical Bill Review and Audit
Medical Bill Review and AuditMedical Bill Review and Audit
Medical Bill Review and AuditScott Fuqua
 
Information Exchange Workgroup Provider Directory Task Force 1-24-11
Information Exchange Workgroup Provider Directory Task Force 1-24-11 Information Exchange Workgroup Provider Directory Task Force 1-24-11
Information Exchange Workgroup Provider Directory Task Force 1-24-11 Brian Ahier
 
Program Overview and Prepare to Review Reported Data
Program Overview and Prepare to Review Reported DataProgram Overview and Prepare to Review Reported Data
Program Overview and Prepare to Review Reported DataMarket iT
 
Fy 2021 hrsa operational site visit updates 2021.09.08
Fy 2021 hrsa operational site visit updates 2021.09.08Fy 2021 hrsa operational site visit updates 2021.09.08
Fy 2021 hrsa operational site visit updates 2021.09.08Compliatric
 
Exploring the Revised Medicare 855 Enrollment Form for 2024
Exploring the Revised Medicare 855 Enrollment Form for 2024Exploring the Revised Medicare 855 Enrollment Form for 2024
Exploring the Revised Medicare 855 Enrollment Form for 2024Conference Panel
 
Understanding HIPAA / HITECH as a Mail Service Provider
Understanding HIPAA / HITECH as a Mail Service ProviderUnderstanding HIPAA / HITECH as a Mail Service Provider
Understanding HIPAA / HITECH as a Mail Service ProviderKarla Humphrey
 
Rac Auditslidesforseminars
Rac AuditslidesforseminarsRac Auditslidesforseminars
Rac Auditslidesforseminarsdaileme1
 
D Rac Auditslidesforseminars
D Rac AuditslidesforseminarsD Rac Auditslidesforseminars
D Rac Auditslidesforseminarschambersc
 

Similar to 2023 Compliatric Webinar Series - 340B Recertification and Audit Changes (20)

2023 Compliatric Webinar Series - 340B ESP Overview from a Participating CE
2023 Compliatric Webinar Series - 340B ESP Overview from a Participating CE2023 Compliatric Webinar Series - 340B ESP Overview from a Participating CE
2023 Compliatric Webinar Series - 340B ESP Overview from a Participating CE
 
Translating compliance requirements into action items 340B
Translating compliance requirements into action items 340BTranslating compliance requirements into action items 340B
Translating compliance requirements into action items 340B
 
Translating compliance requirements into action items 340B
Translating compliance requirements into action items 340BTranslating compliance requirements into action items 340B
Translating compliance requirements into action items 340B
 
340B Drug Pricing Under the Microscope
340B Drug Pricing Under the Microscope340B Drug Pricing Under the Microscope
340B Drug Pricing Under the Microscope
 
Webinar: Medicare Diabetes Prevention Program (MDPP) Expanded Model - Enrollm...
Webinar: Medicare Diabetes Prevention Program (MDPP) Expanded Model - Enrollm...Webinar: Medicare Diabetes Prevention Program (MDPP) Expanded Model - Enrollm...
Webinar: Medicare Diabetes Prevention Program (MDPP) Expanded Model - Enrollm...
 
Identifying & resolving 340b duplicate discounts Kalderos
Identifying & resolving 340b duplicate discounts Kalderos Identifying & resolving 340b duplicate discounts Kalderos
Identifying & resolving 340b duplicate discounts Kalderos
 
HRSA Audits What You Need to Prepare For 2016-06-01-final
HRSA Audits What You Need to Prepare For 2016-06-01-finalHRSA Audits What You Need to Prepare For 2016-06-01-final
HRSA Audits What You Need to Prepare For 2016-06-01-final
 
Navigating manufacturer designations for 340 b contract pharmacies compliatric
Navigating manufacturer designations for 340 b contract pharmacies compliatricNavigating manufacturer designations for 340 b contract pharmacies compliatric
Navigating manufacturer designations for 340 b contract pharmacies compliatric
 
Navigating manufacturer designations for 340 b contract pharmacies compliatric
Navigating manufacturer designations for 340 b contract pharmacies compliatricNavigating manufacturer designations for 340 b contract pharmacies compliatric
Navigating manufacturer designations for 340 b contract pharmacies compliatric
 
Medical Bill Review and Audit
Medical Bill Review and AuditMedical Bill Review and Audit
Medical Bill Review and Audit
 
pc15136_brochure
pc15136_brochurepc15136_brochure
pc15136_brochure
 
Information Exchange Workgroup Provider Directory Task Force 1-24-11
Information Exchange Workgroup Provider Directory Task Force 1-24-11 Information Exchange Workgroup Provider Directory Task Force 1-24-11
Information Exchange Workgroup Provider Directory Task Force 1-24-11
 
Program Overview and Prepare to Review Reported Data
Program Overview and Prepare to Review Reported DataProgram Overview and Prepare to Review Reported Data
Program Overview and Prepare to Review Reported Data
 
Fy 2021 hrsa operational site visit updates 2021.09.08
Fy 2021 hrsa operational site visit updates 2021.09.08Fy 2021 hrsa operational site visit updates 2021.09.08
Fy 2021 hrsa operational site visit updates 2021.09.08
 
Fy 2021 hrsa operational site visit updates 2021.09.08
Fy 2021 hrsa operational site visit updates 2021.09.08Fy 2021 hrsa operational site visit updates 2021.09.08
Fy 2021 hrsa operational site visit updates 2021.09.08
 
Exploring the Revised Medicare 855 Enrollment Form for 2024
Exploring the Revised Medicare 855 Enrollment Form for 2024Exploring the Revised Medicare 855 Enrollment Form for 2024
Exploring the Revised Medicare 855 Enrollment Form for 2024
 
Understanding HIPAA / HITECH as a Mail Service Provider
Understanding HIPAA / HITECH as a Mail Service ProviderUnderstanding HIPAA / HITECH as a Mail Service Provider
Understanding HIPAA / HITECH as a Mail Service Provider
 
RAC Audit
RAC AuditRAC Audit
RAC Audit
 
Rac Auditslidesforseminars
Rac AuditslidesforseminarsRac Auditslidesforseminars
Rac Auditslidesforseminars
 
D Rac Auditslidesforseminars
D Rac AuditslidesforseminarsD Rac Auditslidesforseminars
D Rac Auditslidesforseminars
 

More from Compliatric Where Compliance Happens

2024 Compliatric Webinar Series - Managing and Protecting Adverse Patient Eve...
2024 Compliatric Webinar Series - Managing and Protecting Adverse Patient Eve...2024 Compliatric Webinar Series - Managing and Protecting Adverse Patient Eve...
2024 Compliatric Webinar Series - Managing and Protecting Adverse Patient Eve...Compliatric Where Compliance Happens
 
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...Compliatric Where Compliance Happens
 
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdfCompliatric Where Compliance Happens
 
2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...
2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...
2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...Compliatric Where Compliance Happens
 
2024 Compliatric Webinar Series - Components of a Needs Assessment.pdf
2024 Compliatric Webinar Series - Components of a Needs Assessment.pdf2024 Compliatric Webinar Series - Components of a Needs Assessment.pdf
2024 Compliatric Webinar Series - Components of a Needs Assessment.pdfCompliatric Where Compliance Happens
 
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdf
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdf2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdf
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdfCompliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...
2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...
2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...Compliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...
2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...
2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...Compliatric Where Compliance Happens
 
Contracts and Memorandums of Understanding - Requirements and Responsibilities
Contracts and Memorandums of Understanding - Requirements and ResponsibilitiesContracts and Memorandums of Understanding - Requirements and Responsibilities
Contracts and Memorandums of Understanding - Requirements and ResponsibilitiesCompliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...
2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...
2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...Compliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...
2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...
2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...Compliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdf
2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdf2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdf
2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdfCompliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdf
2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdf2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdf
2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdfCompliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...
2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...
2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...Compliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...
2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...
2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...Compliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdf
2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdf2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdf
2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdfCompliatric Where Compliance Happens
 
Compliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdf
Compliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdfCompliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdf
Compliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdfCompliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...
2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...
2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...Compliatric Where Compliance Happens
 
2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptx
2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptx2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptx
2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptxCompliatric Where Compliance Happens
 

More from Compliatric Where Compliance Happens (20)

2024 Compliatric Webinar Series - Managing and Protecting Adverse Patient Eve...
2024 Compliatric Webinar Series - Managing and Protecting Adverse Patient Eve...2024 Compliatric Webinar Series - Managing and Protecting Adverse Patient Eve...
2024 Compliatric Webinar Series - Managing and Protecting Adverse Patient Eve...
 
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
 
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
 
2024 Compliatric Webinar Series - Protecting LGBTQ Patients.pdf
2024 Compliatric Webinar Series - Protecting LGBTQ Patients.pdf2024 Compliatric Webinar Series - Protecting LGBTQ Patients.pdf
2024 Compliatric Webinar Series - Protecting LGBTQ Patients.pdf
 
2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...
2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...
2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...
 
2024 Compliatric Webinar Series - Components of a Needs Assessment.pdf
2024 Compliatric Webinar Series - Components of a Needs Assessment.pdf2024 Compliatric Webinar Series - Components of a Needs Assessment.pdf
2024 Compliatric Webinar Series - Components of a Needs Assessment.pdf
 
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdf
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdf2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdf
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdf
 
2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...
2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...
2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...
 
2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...
2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...
2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...
 
Contracts and Memorandums of Understanding - Requirements and Responsibilities
Contracts and Memorandums of Understanding - Requirements and ResponsibilitiesContracts and Memorandums of Understanding - Requirements and Responsibilities
Contracts and Memorandums of Understanding - Requirements and Responsibilities
 
2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...
2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...
2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...
 
2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...
2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...
2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...
 
2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdf
2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdf2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdf
2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdf
 
2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdf
2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdf2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdf
2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdf
 
2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...
2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...
2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...
 
2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...
2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...
2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...
 
2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdf
2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdf2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdf
2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdf
 
Compliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdf
Compliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdfCompliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdf
Compliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdf
 
2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...
2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...
2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...
 
2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptx
2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptx2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptx
2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptx
 

Recently uploaded

Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Me
Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near MeRussian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Me
Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Memriyagarg453
 
Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510Vipesco
 
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In FaridabadCall Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabadgragmanisha42
 
Call Girls Patiala Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Patiala Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Patiala Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Patiala Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Bareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetBareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetCall Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meetpriyashah722354
 
Call Girls Service In Goa 💋 9316020077💋 Goa Call Girls By Russian Call Girl...
Call Girls Service In Goa  💋 9316020077💋 Goa Call Girls  By Russian Call Girl...Call Girls Service In Goa  💋 9316020077💋 Goa Call Girls  By Russian Call Girl...
Call Girls Service In Goa 💋 9316020077💋 Goa Call Girls By Russian Call Girl...russian goa call girl and escorts service
 
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetErnakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Chandigarh
 
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near MeVIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Memriyagarg453
 
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591adityaroy0215
 
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...Sheetaleventcompany
 
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service available
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service availableCall Girl Raipur 📲 9999965857 whatsapp live cam sex service available
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service availablegragmanisha42
 
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
❤️Call girls in Jalandhar ☎️9876848877☎️ Call Girl service in Jalandhar☎️ Jal...
❤️Call girls in Jalandhar ☎️9876848877☎️ Call Girl service in Jalandhar☎️ Jal...❤️Call girls in Jalandhar ☎️9876848877☎️ Call Girl service in Jalandhar☎️ Jal...
❤️Call girls in Jalandhar ☎️9876848877☎️ Call Girl service in Jalandhar☎️ Jal...chandigarhentertainm
 
Enjoyment ★ 8854095900 Indian Call Girls In Dehradun 🍆🍌 By Dehradun Call Girl ★
Enjoyment ★ 8854095900 Indian Call Girls In Dehradun 🍆🍌 By Dehradun Call Girl ★Enjoyment ★ 8854095900 Indian Call Girls In Dehradun 🍆🍌 By Dehradun Call Girl ★
Enjoyment ★ 8854095900 Indian Call Girls In Dehradun 🍆🍌 By Dehradun Call Girl ★indiancallgirl4rent
 
VIP Call Girl Sector 10 Noida Call Me: 9711199171
VIP Call Girl Sector 10 Noida Call Me: 9711199171VIP Call Girl Sector 10 Noida Call Me: 9711199171
VIP Call Girl Sector 10 Noida Call Me: 9711199171Call Girls Service Gurgaon
 
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetSambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...Sheetaleventcompany
 

Recently uploaded (20)

Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Me
Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near MeRussian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Me
Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Me
 
Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510
 
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In FaridabadCall Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
 
Call Girls Patiala Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Patiala Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Patiala Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Patiala Just Call 9907093804 Top Class Call Girl Service Available
 
Bareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetBareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetCall Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
 
Call Girls Service In Goa 💋 9316020077💋 Goa Call Girls By Russian Call Girl...
Call Girls Service In Goa  💋 9316020077💋 Goa Call Girls  By Russian Call Girl...Call Girls Service In Goa  💋 9316020077💋 Goa Call Girls  By Russian Call Girl...
Call Girls Service In Goa 💋 9316020077💋 Goa Call Girls By Russian Call Girl...
 
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetErnakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near MeVIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
 
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
 
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...
 
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service available
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service availableCall Girl Raipur 📲 9999965857 whatsapp live cam sex service available
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service available
 
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
 
❤️Call girls in Jalandhar ☎️9876848877☎️ Call Girl service in Jalandhar☎️ Jal...
❤️Call girls in Jalandhar ☎️9876848877☎️ Call Girl service in Jalandhar☎️ Jal...❤️Call girls in Jalandhar ☎️9876848877☎️ Call Girl service in Jalandhar☎️ Jal...
❤️Call girls in Jalandhar ☎️9876848877☎️ Call Girl service in Jalandhar☎️ Jal...
 
Enjoyment ★ 8854095900 Indian Call Girls In Dehradun 🍆🍌 By Dehradun Call Girl ★
Enjoyment ★ 8854095900 Indian Call Girls In Dehradun 🍆🍌 By Dehradun Call Girl ★Enjoyment ★ 8854095900 Indian Call Girls In Dehradun 🍆🍌 By Dehradun Call Girl ★
Enjoyment ★ 8854095900 Indian Call Girls In Dehradun 🍆🍌 By Dehradun Call Girl ★
 
VIP Call Girl Sector 10 Noida Call Me: 9711199171
VIP Call Girl Sector 10 Noida Call Me: 9711199171VIP Call Girl Sector 10 Noida Call Me: 9711199171
VIP Call Girl Sector 10 Noida Call Me: 9711199171
 
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetSambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
 

2023 Compliatric Webinar Series - 340B Recertification and Audit Changes

  • 1. 340B Recertification & Audit Changes/Tips Ryan DiGiovanni, PharmD, 340B ACE ryan_digiovanni@rush.edu
  • 2. Disclosures • No conflict of interest • Information provided should not be construed as legal advice.
  • 3. Bio Ryan DiGiovanni – PharmD, 340B ACE Founder - EPL Health • Build and support 340B compliance & operations for covered entities (CE) • Entities we serve: FQHC, FQHC-LA, DSH, CAH, RW Clinics 340B Manager- Rush University Health System • 2 Disproportionate Share Hospital (DSH) • 1 Hemophilia Treatment Center (HTC) • 700+ Contract Pharmacy • 3 Third Party Administrators 340B Satellite Office 340B Coordinator Expansion & Growth All Vendor Management Compliance & Audit Consolidated Reporting
  • 4. Agenda + Hot Topics + Audit Trends & Readiness + 340B Data Request Review
  • 5. Poll 1. What entity type are you? a. Hospital b. Grantee 2. What do we want to spend most of our time on? a. 340B Hot Topics & HRSA Audit Impact b. Annual Recertification c. HRSA Audit Data Request List
  • 6. Hot Topics: Timeline of Events 2019 Guidances Not Legally Binding Trump Administration issued an executive order (Federal Register, 84 Fed. Reg. 55235-55238 Oct 15, 2019) that rendered guidance documents published by federal agencies as non-binding and not legally enforceable. Manufacturer Restrictions Begin Effective July 1, 2020, Eli Lilly announces it will no longer sell Cialis at 340B ceiling prices to covered entities through contract pharmacy arrangements 2020 2020 HRSA Loosens Audit Findings The Government Accountability Office (GAO) issues report, stating HRSA began to relax its auditing standards, only issuing findings non-compliance that are directly related to 340B Program Statute. 2022 Genesis v. Azar Appeal Genesis appeal argued HRSA audit findings were based on interpretation of ‘patient’ defined in guidance, contradicting the plain language of the law and overextended HRSA’s enforcement capability HRSA ultimately reinstated Genesis in the 340B Program, voided its audit, and the district court dismissed the lawsuit. 2023 1st Ruling in favor of Manufacturers U.S. Court of Appeals for the 3rd Circuit rule in favor of Sanofi-Aventis U.S. v. HHS et al. Not required to provide 340B price at contract pharmacy. Cases raising similar legal questions are pending in the District of Columbia and 7th Circuits.
  • 7. Hot Topics: Genesis V Agar & Guidance on Patient Definition Diversion
  • 8. Hot Topics: Op-Ed ❖ Background/Discussion Currently, HRSA’s authority is limited only to program statutes and regulations* - Mega-guidance and other common guidelines (i.e. Patient Definition) are not enforceable findings during a HRSA audit* ❖ Tips/Warnings - May drive greater attention to enforceable laws/regulations. Recommend special attention to specific aspects of program: - Accuracy/Eligibility information in OPAIS database - Recertification/Registration - Policy & Procedure - annual review and update - Duplicate Discount Prevention - Medicaid Exclusion File, State Policy - Maintained auditable records - Compliance with HRSA Audit - *based on presentation date 02/21/2023. Statements outlined are opinion based and/or subject to change
  • 10. Recertification - General ❖ Background/Discussion - Annual recertification is mandatory for 340B covered entities - Authorizing Official & Primary Contact get email notifications ❖ Requirements - Must ensure all information is accurate and up to date - Must update and attest before recertification window ends - ONLY AO can Attest (PC can update/make changes) Entity Type Recertification Window FQHCs & Most Grantee January 30, 2023 - February 27, 2023 Hospitals Summer 2023 Title X family planning clinics, STD, TB clinics No dates yet
  • 11. Recertification - General ❖ Tips/Warnings - Have MCR/Grant documents ready for upload - Verify addresses match on eligibility forms to OPAIS - Ensure each registered site is still operational/eligible - Grantees: falls under scope of grant - Hospitals: outpatient charges/expenses on MCR lines 50-118* - Have you Medicaid billing numbers and/or NPI numbers ready - Ensure contact information for AO and PC is correct ❖ Tools/References - Get help: - ApexusAnswers@340bpvp.com - 888-340-2787 - Online Resources: - Recertifying a CE *FAQ ID: 4301. HRSA 340B FAQ Search (340bpvp.com)
  • 12. Start Session Go to links provided in Autorizing Official (AO) or Primary Contact (PC) email. Sign in to HRSA 340B OPAIS database (Office of Pharmacy Affairs 340B OPAIS (hrsa.gov)) to start. Recertification tasks will appear in My Dashboard section under ‘My Task’ tab’. Click on ‘Recertification’ Summary Page The recertification summary page will outline items for you that must be updated, and items that should be reviewed. “Update” = required, “Review” = Recommended. Read these then hit ‘Continue AO Signs & Attests After all information is updated and reviewed, the Authorizing Official must check the attestation box, and ‘Submit’ Go Through Each Tab - Go through each tab Qualification Info, Attachments Info, Medicaid Billing, Parent/Child. - Read any ‘update’ or ‘review’ messages. - Click the Edit link to review the details pages and make necessary updates.
  • 13. Recertification - Uploading Attachments ❖ Background/Discussion - This is usually the biggest issue requiring additional follow up from HRSA ❖ Tips/Warnings - Only Microsoft Excel (xlsx) and Adobe PDF formats are allowed. - File size is limited to 50MB. - Files must not be password protected. - Number of uploaded files must not exceed 10 files per submission ❖ Tools/References - ApexusAnswers@340bpvp.com - 888-340-2787 - Uploading Documents
  • 14. Recertification - Cost Report - If you change the entity's Qualification Information during recertification or if the most recent cost report is out of date, the system will prompt you to upload updated supporting documentation from the latest Medicare cost report. - If you change the entity’s Filing Date, and if the Filing Date is more than 5 months and 5 days after the Cost Reporting Period end date then the system will display a warning message and require you to upload the signed/dated Worksheet S from your latest filed Medicare Cost Report.
  • 15. Changing AO - Recertification The current AO or PC may submit an AO change request. Only an AO change can be requested in a Change Request when the entity is undergoing recertification. On the Covered Entity Details page, type the email address for the new AO and click the Search button.
  • 16. Medicaid - Recertification This information is used to populate the medicaid exclusion file ‘At this site, will the covered entity bill Medicaid fee-for-service for drugs purchased at 340B prices? Yes = Carve-in, No = Carve out Duplicates cannot be created because upon the save in the Edit Medicaid and NPI Info by State pop-up window, the duplicates will be ignored. However, if duplicates already exist, it is up to the AO and PC to correct them either by associating each duplicated number with a different State or removing the duplicates from the current State.
  • 18. HRSA Audit Agenda What to Expect: Introductions – Consider one person to coordinate if remote Scripted Reason for Audit Agenda timing will vary Auditor will review housekeeping items that may still need to be uploaded Begin with a general overview of program and auditor questions Sampling, Transaction Testing, Provider Review, Claim Review Follow Up On Any Outstanding Items Closing
  • 19. HRSA Selection Criteria Maximum number of random samples selected is 56 28 samples from largest universe If any universe is 300 or less there will never be more than 10% 5 samples are judgmental which will always come from the largest dataset ❖ Background/Discussion Since 2020, HRSA has implemented consistent data sampling practices:
  • 20. Provider Administered Drugs Sample • Time of Dispense or Administration • Patient Status • Drug Order and Dose • Provider Name - If Health Care Professional Stance utilized, show documentation to substantiate care • Location – If not from an eligible location, demonstrate the continuum of care via primary care visit or referral documentation. • Payer
  • 21. Retail Claims Drug Sample • Date of Visit to Substantiate Care • Location Where Prescription Was Written • Prescription Order • Medication Present in Med list • Medication Present in Provider Documentation • Referral Origination and Care Note Back (if applicable, best practice) • Payer – If in-House Retail and FFS Medicaid will want to see clarification codes
  • 22. Billing Claim Form Review ❖ Background/Discussion If carving-in Medicaid, expect auditor to review billing - Will need to verify NPI-UB04 Box 56 & CMS 1500 Box 33 - Confirmation of any state modifiers ❖ Requirements - Only required to upload Medicaid FFS claim
  • 24. 340B Audit Data Request List ❖ Background/Discussion Reviewed and updated beginning of every fiscal year ❖ Requirements/New Information 1. Policy & Procedures 2. Eligibility 3. 340B Universe for Sample Period 4. Provider List 5. Purchasing 6. Contract Pharmacy 7. Entity-Owned Pharmacy 8. Self-Disclosures 9. Medicaid Billing 10. Re-audit ❖ Tips/Warnings ❖ Tools/References - 340B Data Request List Sample pdf
  • 25. 1. Policies & Procedures ❖ Background/Discussion - All CE’s: loosened eligibility of providers, locations and acceptable patient records during public health emergency - Hospitals: Definition of eligible site when location is not on the MCR yet or for special circumstance ❖ Requirement - Policy & Procedures must reflect the covered entities eligible location definition, provider and record-keeping requirements to allow for this ❖ Tips/Warnings - Ensure P&P’s updated to provide entity this wiggle room - Auditor may ask about emergency activations of locations within sampling period ❖ Tools/References - HRSA FAQ ID: 4301 - Public Health Emergency Considerations
  • 26. 2.B. Eligibility - Hospitals ❖ Background/Discussion - More transparency of site eligibility when reviewing sample data ❖ Requirement New in FY23: Section 2B - Include all applicable Medicare Cost Reports - Most recently filed MCR for the start of the audit period; - MCR used at the time of the last recertification; and - MCR filed since the start of the sample period through the date of audit - The encrypted signature on Worksheet S must be provided with all MCRs -
  • 27. 2.G. Eligibility - Hospitals ❖ New Requirements 2.C - Item G Added FY21 - The 340B ID - Name of each offsite outpatient facility as identified on OPAIS - Address of the off-site outpatient facility - Worksheets A & C: Line Number and Cost Center Description - Trial balance name and department code/account - The location code or shorthand used to identify the site in the electronic health record (EHR) - Indicate if 340B drugs are utilized during encounters at the site -
  • 28. 2.E. Eligibility - Hospitals ❖ Background/Discussion HRSA wants hospital eligibility documents to be easier to decipher ❖ New Requirements 2.E. Hospitals Requiring Contract with State or Local Government - New FY22: must highlight the following in the contract: ■ Provision whereby indigent care provided by Hospital ■ Name of Hospital and Government Agency ■ Signatures of Hospital and Government Agency ■ Effective Dates of the Contract Private non-profit and hospitals granted government powers must prove non-profit status documentation. - IRS Form 990, Hospital Charter, Articles of incorporation, Bylaws, 501(c)(3)
  • 29. 2. Eligibility - Grantees ❖ Background/Discussion - Auditor will likely go through services provided at each associated clinic during an opening conference. - Crosswalks create bridge to cipher eligible locations listed on OPAIS to EHR record locations to Billing/Shipping Locations - Will make for seamless preparation and audit ❖ Requirements - Notice of Grant Award and/or sub grantee documentation - EHB Forms 5A and 5B. 5C is not on list but have available as well. - EHB Crosswalk – Include a list of locations where health care services are provided for which the grantee deems itself responsible ❖ Tips/Warnings Creating EHB Crosswalk: 1. Start with OPAIS extract 2. Crosswalk each associated site’s physical address, verify they match the EHB 3. Add bill to and ship to columns and populate with appropriate addresses 4. Add location code or shorthand to identify the site in the health record 5. Include additional columns to indicate if actively purchasing 340B drugs and add billing numbers if carving in Medicaid. ❖ Tools/References - Apexus Sample Data Request - 340B Crosswalk - Basic Template
  • 30. 3.A. Universe & Program Narrative ❖ Requirements 3.A: Not New - Include a narrative describing the methodology and system or software used to gather the data: note any limitations, exclusions, and inclusions (e.g., reversals, direct purchases, etc.) Universe Methodology/System/ Software Report Name(s) Notes Mixed Use Mixed Use TPA Includes Reversals and direct purchases, explain limitations, or any exclusions Child Site EHR or TPA In-House Rx TPA Contract Rx TPA
  • 31. 3.A. Universe & Program Narrative ❖ New Requirements 3A. - Define each area of service on the spreadsheet(s) with column headings name and indicate which area the spreadsheet represents ❖ Tips/Warnings Copy the column headers and add into the program narrative Create a key for abbreviations and/or unknown terms - For example: - CSN = Contact Serial Number = Unique Patient ID - MRN = Medical Record Number - ESN = Encounter Serial Number
  • 32. 3.A. Universe & Program Narrative ❖ Tips/Warnings - Review ALL data prior to upload - Remove non-covered outpatient drugs - exclude limiting definition drugs (vaccines), orphan drugs - pvp-value added drugs (use pvp price file for this) - Only report data elements that have been asked for - REMOVE PHI (just Rx number, MRN, or tracking number) - BUT Keep copies of original records on file for better cross-walking during audit period
  • 33. 4. Provider List ❖ Requirements - Name - NPI - Employment type (Employed, Resident, Contract) - Start Date - End Date ❖ Tips/Warnings - Create ‘Type 2’ dimension- table to address any potential gaps in employment and/or change in employment type - Be prepared to show the auditor proof of employment, contract, or credentialing for providers during the onsite/remote audit Provider Map ID First Name Last Name NPI Employment Type Start Date End Date isActive 1 John Doe 1234564789 Dedicated 1/1/2010 3/1/2015 N 2 John Doe 1234564789 Contracted 3/2/2015 Y
  • 34. 5. Purchasing Docs ❖ Requirements - List all accounts – for all universes – including if applicable (340B, GPO, WAC, CSOS) by 340B ID - Include wholesaler name - Include a column for bill to and ship to which will assist in OPAIS address verification - Provide Invoice example for each account – embed or list corresponding file name - Provide all purchases (340B ONLY) - embed or list corresponding spreadsheet name ❖ Tips/Warnings - Update on a rolling 6-month basis to be in HRSA audit ready state - Create ‘Type 2’ dimension- table to address any potential gaps in employment and/or change in employment type
  • 35. 5. Purchasing Crosswalk Example Clinic / Hospital / Retail Account Location 340B ID Ship To Address Bill To Address ACCOUN T # DESIGNATI ON WHOLESALE R Invoice Name Reference Purchasing Record Off-Site Clinic CE Physicians Group HRSA ID 336 S. Jefferson 113 W. Hickory XYZ 340B Add Name 5.B. HRSA ID Invoice 7805XXX 5.C. HRSA ID Wholesaler Purchasing Record Off-Site Clinic CE Physicians Group HRSA ID 336 S. Jefferson 113 W. Hickory XYZ GPO Add Name 5.B. HRSA ID Invoice 387XXXXX NA Hospital CE Hospital HRSA ID 113 W. Hickory Street 113 W. Hickory XYZ GPO Add Name 5.B. Mixed Use GPO Invoice 995XXXXX NA Hospital CE Hospital HRSA ID 113 W. Hickory Street 113 W. Hickory XYZ 340B Add Name 5.B. HRSA ID 340B Invoice 3087XXXXXX 5.C. HRSA ID Wholesaler Purchasing Record
  • 36. 6A. Contract Pharmacy Crosswalk ❖ New Requirements - 6.A. must disclose whether pharmacy is being used by the covered entity - 6.C. Provide last Independent Audit of Contract Pharmacies - 6.D. Provide supporting documentation of internal contract pharmacy audits during start of sample period through date of audit. ❖ Tips/Warnings - Create ‘Type 2’ dimension- table 1. Can use OPAIS Extract of all contact pharmacies to get you started and minimize to the following columns: - 340B ID, Pharmacy Name, Address 1, Address 2, City, State, Zip, Contract Approval Date 2. Then add the following additional columns: - TPA, Pay on: Dispense or Replenishment, True Up Terms, Utilized or Not Utilized, Wholesaler, Account Number, Invoice, Contract Name
  • 37. CONTRACT PHARMACY CROSSWALK EXAMPLE 340 B ID Retail Account Location Address Contract Approval Date TPA Pay on True Up Active Wholesaler Account # Invoice Name Contract Name HRS A ID Contract Pharmacy Uptown Drug Store N Bus hwy date from extract Macro Replenis hment 180 Utilized Cardinal XYZ or 123 CAHXXXXXX-00 copy of invoice List contract file name when first registered or embed copy HRS A ID Contract Pharmacy Drug Stores on the Boulevard S BLVD Ste A date from extract Macro Replenis hment 180 Utilized Cardinal XYZ or 124 CAHXXXXXX-00 copy of invoice List contract file name when first registered HRS A ID Contract Pharmacy Walgreens #0XYZ S BLVD date from extract Walgree ns Dispens e 60 Utilized Amerisource XYZ or 126 CAHXXXXXX-00 Walgreens copy of invoice List contract file name when first registered HRS A ID Contract Pharmacy PHY S Jefferso n date from extract ScriptPr o Dispens e 60 Utilized Amerisource XYZ or 127 CAHXXXXXX-00 Walgreens copy of invoice List contract file name when first registered HRS A ID Contract Pharmacy Walmart 001 Grand Ave date from extract Macro Replenis hment 180 Utilized McKesson XYZ or 128 CAHXXXXXX-00 Walmart Invoice_AXXXXX List contract file name when first registered HRS A ID Contract Pharmacy Walmart 005 Range RD date from extract Macro Replenis hment 180 Not Utilized McKesson XYZ or 130 Not Utilized List contract file name when first registered if in audit window, if not list term date or NA
  • 38. 7. Entity-Owned Pharmacies ❖ New Requirements Provide a list of pharmacies, other than contract pharmacies utilized during the start of the sample period through the audit start date. - Pharmacy name and address - Whether pharmacy is located within a registered off-site facility/grant-associated Site Type of pharmacy (Retail/Community, Infusion, Specialty, Compounding, Mixed-Use) - Documentation to demonstrate ownership - Pharmacy license, Business license, Certificate of liability insurance, or Listing of pharmacy on the CEs grant or MCR and corresponding trial balance ❖ Tips/Warnings - Also adding in OPAIS Pharmacy ID, OPAIS Contract ID, Pharmacy NPI number would provide more efficient tracking and reference ID columns. - Can use these columns for Xlookup/Vlookup functions to audit pharmacy dispensing data across all pharmacies/TPAs. ❖ Tools/References 340B Crosswalk - Basic Template
  • 39. 9. Medicaid Documents ❖ Requirements - Provide Medicaid FFS billing document for each covered entity site (340B ID) that carves in - Every NPI, every Medicaid number, for EVERY 340B ID 340B ID State State Requirements NPI(s) State assigned Medicaid number(s) Medicaid FFS Claim Form CAH12345-00 MN UD 123 XYZ [Embedded document] CAH12345-01 MN UD 1234 XYZ [Embedded document] CAH12345-02 MN UD 12345 XYZ [Embedded document]
  • 40. Key Takeaway - 340B DRL - 340B Program Narrative, with data methodology table, and column header crosswalk - Location Crosswalk - Purchasing Crosswalk - Contract Pharmacy Crosswalk - Medicaid Crosswalk
  • 42. 340B News: Genesis v Agar Genesis Healthcare Inc. v Alex Azar: Genesis, an FQHC, removed from 340B program after 340B audit findings of Diversion. (qualified rx’s as 340B eligible from ‘non-eligible locations’) Bullet Points: • After being removed from 340B, Genesis filed suite that argued that the audit findings, which were based on adherence to HRSA’s interpretation of ‘patient’ defined in guidance, contradict the plain language of the law and overextended HRSA’s enforcement capability • HRSA ultimately reinstated Genesis in the 340B Program, voided its audit, and the district court dismissed the lawsuit. • Genesis has since appealed the dismissal, pressing the court for a declaratory judgment that the 340B patient definition issued through guidance is illegal. Oral arguments for the appellate case were heard in March 2022. Historical perspective regarding the case: • In 2019, the Trump Administration issued an executive order (Federal Register, 84 Fed. Reg. 55235-55238 Oct 15, 2019) that rendered guidance documents published by federal agencies as non-binding and not legally enforceable. • Mfg have taken advantage by restricting 340B drugs through contract pharmacy channels, as outlined in non-binding guidance • The Government Accountability Office (GAO) issued a report in December 2020 on HRSA’s efforts to oversee CE compliance with 340B Program requirements. The report noted that, starting in the fall of 2019, HRSA began to relax its auditing standards by which it would only issue findings for areas of non-compliance that are directly related to requirements stipulated in the 340B Program statute. • 340B Statute: https://www.hrsa.gov/sites/default/files/hrsa/rural-health/phs-act-section-340b.pdf
  • 43. 340B News: Genesis v Agar Conclusion: Broadening the patient definition may provide CEs with significant value in terms of 340B savings optimization, and may be permissible according to law, given the lack of specificity of “patient definition” outlined in 340B Program statute and regulations. Considerations: • Elements of case are directly applied to grantee, not a hospital • Current HRSA audit standards reflect the agency’s limited enforcement authority, HOWEVER, these standards could evolve should they receive rule-making authority and/or the ability to enforce 340B Program guidance. Potential Next Steps: • Assess for scenarios where a “continuum of care” relationship may apply • Review non-reimbursable hospital departments (e.g., Line 190 clinics) that may be integral to the CE. • Quantify the financial impact of broadening the Patient definition • Ensure any modifications to patient definition are clearly articulated in policies and procedures.